MVP
Basic information
Region (hg38): 16:29820394-29848039
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (108 variants)
- not_provided (10 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MVP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005115.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 102 | 111 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 102 | 11 | 4 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MVP | protein_coding | protein_coding | ENST00000357402 | 14 | 27641 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.76e-8 | 0.999 | 125603 | 0 | 145 | 125748 | 0.000577 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.02 | 431 | 566 | 0.762 | 0.0000376 | 5684 |
Missense in Polyphen | 227 | 298.44 | 0.76061 | 2953 | ||
Synonymous | 0.564 | 235 | 246 | 0.954 | 0.0000162 | 1915 |
Loss of Function | 2.87 | 18 | 36.8 | 0.489 | 0.00000183 | 412 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000814 | 0.000809 |
Ashkenazi Jewish | 0.000300 | 0.000298 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00185 | 0.00157 |
European (Non-Finnish) | 0.000653 | 0.000633 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000362 | 0.000359 |
Other | 0.000492 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Required for normal vault structure. Vaults are multi- subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo- cytoplasmic transport. Down-regulates IFNG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. {ECO:0000269|PubMed:15133037, ECO:0000269|PubMed:16418217, ECO:0000269|PubMed:16441665}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System;EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.797
- rvis_EVS
- -0.81
- rvis_percentile_EVS
- 12.05
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- Y
- hipred_score
- 0.520
- ghis
- 0.558
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mvp
- Phenotype
- normal phenotype;
Zebrafish Information Network
- Gene name
- mvp
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- protein transport;negative regulation of signaling;negative regulation of protein autophosphorylation;ERBB signaling pathway;neutrophil degranulation;mRNA transport;negative regulation of protein tyrosine kinase activity
- Cellular component
- extracellular region;nucleus;nuclear pore;cytoplasm;cytosol;cytoskeleton;membrane;secretory granule lumen;perinuclear region of cytoplasm;extracellular exosome;ficolin-1-rich granule lumen
- Molecular function
- protein binding;protein kinase binding;protein phosphatase binding;identical protein binding